Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
67%(6 trials)

Phase Distribution

Ph phase_1
4
44%
Ph phase_3
1
11%
Ph phase_4
4
44%

Phase Distribution

4

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
4(44.4%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(9)

Detailed Status

Completed9

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (44.4%)
Phase 31 (11.1%)
Phase 44 (44.4%)

Trials by Status

completed9100%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_4

Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?

NCT00444145
completedphase_1

Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux

NCT00864396
completedphase_3

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

NCT01005719
completedphase_4

Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer

NCT00239551
completedphase_4

Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

NCT00230516
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT00444145Phase 4

Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?

Completed
NCT00864396Phase 1

Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux

Completed
NCT01005719Phase 3

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

Completed
NCT00239551Phase 4

Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer

Completed
NCT00230516Phase 4

Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

Completed
NCT00903448Phase 4

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

Completed
NCT01045967Phase 1

Lansoprazole 30 mg DR Capsule Fasting Study

Completed
NCT01046253Phase 1

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Completed
NCT01046084Phase 1

Lansoprazole 30 mg DR Capsule Replicate Food Study

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9